Overview

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
0
Participant gender:
All
Summary
We sought to determine if there is a benefit to using an insulin drip to control hyperglycemia in the surgical critical care unit for patients who undergo general and vascular surgery.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Genesys
Collaborator:
Novo Nordisk A/S
Treatments:
Insulin
Insulin, Globin Zinc
Criteria
Inclusion Criteria: Patients undergoing a general or vascular surgical procedure requiring
admission to the surgical intensive care unit as a result of ventilatory requirement,
vasopressor support, or physiologic instability

-

Exclusion Criteria:

- Under age 18